If migraine benefits prove to be real in rigorous studies, tirzepatide could become a game-changer for the large population of people who suffer from both obesity and migraines, two conditions that exacerbate each other in a vicious cycle
Symptoms include sharp abdominal pain, pain near the shoulder blades, jaundice, dark urine, clay-colored stool, and gastrointestinal discomfort such as nausea, bloating, and vomiting
All bariatric surgeries are not created equal: insights from mechanistic comparisons
Liraglutide and semaglutide are both GLP-1 agonists, medications capable of helping patients with weight loss, but they differ in their dosing schedule and overall effectiveness
This effect may diminish over time with continued use and requires caution in patients with severe gastrointestinal disease or gastroparesis
More trials are needed to fully elucidate the safety of the novel triple-receptor-agonist retatrutide